BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 14638596)

  • 1. Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS.
    Théberge J; Al-Semaan Y; Williamson PC; Menon RS; Neufeld RW; Rajakumar N; Schaefer B; Densmore M; Drost DJ
    Am J Psychiatry; 2003 Dec; 160(12):2231-3. PubMed ID: 14638596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers.
    Théberge J; Bartha R; Drost DJ; Menon RS; Malla A; Takhar J; Neufeld RW; Rogers J; Pavlosky W; Schaefer B; Densmore M; Al-Semaan Y; Williamson PC
    Am J Psychiatry; 2002 Nov; 159(11):1944-6. PubMed ID: 12411236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton magnetic resonance spectroscopy of the anterior cingulate region in schizophrenia.
    Deicken RF; Zhou L; Schuff N; Weiner MW
    Schizophr Res; 1997 Oct; 27(1):65-71. PubMed ID: 9373896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mania, glutamate/glutamine and risperidone in pediatric bipolar disorder: a proton magnetic resonance spectroscopy study of the anterior cingulate cortex.
    Moore CM; Biederman J; Wozniak J; Mick E; Aleardi M; Wardrop M; Dougherty M; Harpold T; Hammerness P; Randall E; Lyoo IK; Renshaw PF
    J Affect Disord; 2007 Apr; 99(1-3):19-25. PubMed ID: 17005256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: investigation of anterior cingulate, dorsolateral prefrontal cortex and thalamus.
    Yoo SY; Yeon S; Choi CH; Kang DH; Lee JM; Shin NY; Jung WH; Choi JS; Jang DP; Kwon JS
    Schizophr Res; 2009 Jun; 111(1-3):86-93. PubMed ID: 19406622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1H-MRS at 4 tesla in minimally treated early schizophrenia.
    Bustillo JR; Rowland LM; Mullins P; Jung R; Chen H; Qualls C; Hammond R; Brooks WM; Lauriello J
    Mol Psychiatry; 2010 Jun; 15(6):629-36. PubMed ID: 19918243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An in vivo proton magnetic resonance spectroscopy study of schizophrenia patients.
    Stanley JA; Williamson PC; Drost DJ; Rylett RJ; Carr TJ; Malla A; Thompson RT
    Schizophr Bull; 1996; 22(4):597-609. PubMed ID: 8938914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced parkinsonism in relation to choline-containing compounds measured by 1H-MR spectroscopy in putamen of chronically medicated patients with schizophrenia.
    Yamasue H; Fukui T; Fukuda R; Kasai K; Iwanami A; Kato N; Kato T
    Int J Neuropsychopharmacol; 2003 Dec; 6(4):353-60. PubMed ID: 14604450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grey matter and social functioning correlates of glutamatergic metabolite loss in schizophrenia.
    Aoyama N; Théberge J; Drost DJ; Manchanda R; Northcott S; Neufeld RW; Menon RS; Rajakumar N; Pavlosky WF; Densmore M; Schaefer B; Williamson PC
    Br J Psychiatry; 2011 Jun; 198(6):448-56. PubMed ID: 21628707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton magnetic resonance spectroscopy study of brain metabolite changes after antipsychotic treatment.
    Szulc A; Galinska B; Tarasow E; Waszkiewicz N; Konarzewska B; Poplawska R; Bibulowicz D; Simonienko K; Walecki J
    Pharmacopsychiatry; 2011 Jun; 44(4):148-57. PubMed ID: 21710405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.
    O'Neill J; Levitt J; Caplan R; Asarnow R; McCracken JT; Toga AW; Alger JR
    Neuroimage; 2004 Apr; 21(4):1781-9. PubMed ID: 15050598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher glutamate+glutamine and reduction of N-acetylaspartate in posterior cingulate according to age range in patients with cognitive impairment and/or pain.
    Fayed N; Andrés E; Viguera L; Modrego PJ; Garcia-Campayo J
    Acad Radiol; 2014 Sep; 21(9):1211-7. PubMed ID: 24981958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between aberrant neuronal activation in the pregenual anterior cingulate, altered glutamatergic metabolism, and anhedonia in major depression.
    Walter M; Henning A; Grimm S; Schulte RF; Beck J; Dydak U; Schnepf B; Boeker H; Boesiger P; Northoff G
    Arch Gen Psychiatry; 2009 May; 66(5):478-86. PubMed ID: 19414707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy.
    Tandon N; Bolo NR; Sanghavi K; Mathew IT; Francis AN; Stanley JA; Keshavan MS
    Schizophr Res; 2013 Aug; 148(1-3):59-66. PubMed ID: 23791389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related changes in anterior cingulate cortex glutamate in schizophrenia: A (1)H MRS Study at 7 Tesla.
    Brandt AS; Unschuld PG; Pradhan S; Lim IA; Churchill G; Harris AD; Hua J; Barker PB; Ross CA; van Zijl PC; Edden RA; Margolis RL
    Schizophr Res; 2016 Apr; 172(1-3):101-5. PubMed ID: 26925800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regarding "Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study".
    Théberge J; Jensen JE; Rowland LM
    Biol Psychiatry; 2007 May; 61(10):1218-9; author reply 1219-20. PubMed ID: 16950227
    [No Abstract]   [Full Text] [Related]  

  • 18. Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder.
    Yücel M; Wood SJ; Wellard RM; Harrison BJ; Fornito A; Pujol J; Velakoulis D; Pantelis C
    Aust N Z J Psychiatry; 2008 Jun; 42(6):467-77. PubMed ID: 18465373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced cingulate glutamate/glutamine-to-creatine ratios in adult patients with attention deficit/hyperactivity disorder -- a magnet resonance spectroscopy study.
    Perlov E; Philipsen A; Hesslinger B; Buechert M; Ahrendts J; Feige B; Bubl E; Hennig J; Ebert D; Tebartz van Elst L
    J Psychiatr Res; 2007 Dec; 41(11):934-41. PubMed ID: 17303167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre
    Egerton A; Broberg BV; Van Haren N; Merritt K; Barker GJ; Lythgoe DJ; Perez-Iglesias R; Baandrup L; Düring SW; Sendt KV; Stone JM; Rostrup E; Sommer IE; Glenthøj B; Kahn RS; Dazzan P; McGuire P
    Mol Psychiatry; 2018 Nov; 23(11):2145-2155. PubMed ID: 29880882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.